Roche Launches $5.7B Hostile Bid For Illumina
Swiss drug maker Roche Holding Ltd. on Wednesday made a $5.7 billion hostile bid for gene sequencing company Illumina Inc., saying it had gotten the cold shoulder from Illumina's board....To view the full article, register now.
Already a subscriber? Click here to view full article